NTC

NF Trinity Capital Portfolio holdings

AUM $626M
1-Year Est. Return 3.16%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+3.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$626M
AUM Growth
+$10.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
51
New
Increased
Reduced
Closed

Top Buys

1
+$5.16M
2
+$3.14M
3
+$2.49M
4
BMY icon
Bristol-Myers Squibb
BMY
+$2.19M
5
AMZN icon
Amazon
AMZN
+$1.02M

Top Sells

1
+$14M
2
+$10.9M
3
+$9.73M
4
META icon
Meta Platforms (Facebook)
META
+$9.59M
5
FNSR
Finisar Corp
FNSR
+$8.45M

Sector Composition

1 Communication Services 32.8%
2 Consumer Discretionary 28.25%
3 Financials 12.43%
4 Healthcare 9.71%
5 Technology 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
26
Gilead Sciences
GILD
$174B
$5.65M 0.9%
86,959
TAL icon
27
TAL Education Group
TAL
$6.86B
$5.22M 0.83%
144,791
-84,000
IBB icon
28
iShares Biotechnology ETF
IBB
$8.15B
$4.83M 0.77%
43,200
DB icon
29
Deutsche Bank
DB
$58.3B
$4.33M 0.69%
533,225
SAGE
30
DELISTED
Sage Therapeutics
SAGE
$3.07M 0.49%
19,313
-13,193
BKNG icon
31
Booking.com
BKNG
$5.58B
$3.07M 0.49%
+1,760
VTRS icon
32
Viatris
VTRS
$15.4B
$2.83M 0.45%
100,000
INCY icon
33
Incyte
INCY
$18.9B
$2.67M 0.43%
31,000
SLB icon
34
SLB Ltd
SLB
$74.7B
$2.42M 0.39%
55,500
MNK
35
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$2.22M 0.35%
102,000
IOVA icon
36
Iovance Biotherapeutics
IOVA
$1.36B
$2.17M 0.35%
228,442
VKTX icon
37
Viking Therapeutics
VKTX
$3.92B
$1.39M 0.22%
140,000
FLNT
38
Fluent
FLNT
$96.6M
$1.09M 0.18%
32,467
ARAV
39
DELISTED
Aravive, Inc. Common Stock
ARAV
$287K 0.05%
40,816
MELI icon
40
Mercado Libre
MELI
$86.7B
– –
-21,189
APLS icon
41
Apellis Pharmaceuticals
APLS
$5.19B
– –
-357,142
CRM icon
42
Salesforce
CRM
$171B
– –
-28,088
GS icon
43
Goldman Sachs
GS
$255B
– –
-3,700
HIMX
44
Himax Technologies
HIMX
$1.54B
– –
-470,000
PM icon
45
Philip Morris
PM
$250B
– –
-63,000
TEVA icon
46
Teva Pharmaceuticals
TEVA
$34.7B
– –
-53,000
VIPS icon
47
Vipshop
VIPS
$7.19B
– –
-52,644
XLRN
48
DELISTED
Acceleron Pharma
XLRN
– –
-14,369
CELG
49
DELISTED
Celgene Corp
CELG
– –
-107,491
FNSR
50
DELISTED
Finisar Corp
FNSR
– –
-391,000
1
2